Orthopedics This Week | February 16, 2016 | Page 21
ORTHOPEDICS THIS WEEK
VOLUME 12, ISSUE 6 | FEBRUARY 16, 2016
So what were they doing right? “First
of all,” says Dr. Riew, “the neck ‘pain’
was probably nerve compression
pain. All we had to do was take the
pressure off the nerves. We are also
very meticulous about preserving
the integrity of the posterior cervical
spine muscles. We open very carefully
under microscope visualization, often
using Metzenbaum scissors blunt dissection. We also close meticulously
and in multiple layers. If you take
great care with the dissection, the
patient only loses a little blood and
the muscles heal much better and
continue to function normally.”
“Midline axial pain probably won’t
improve. However, if the pain is in
the upper trapezial area, then it will
improve in a high percentage of cases.”
“Many surgeons in the U.S. don’t do
laminoplasty either because it takes a
long time, they don’t know how to do
it or because it doesn’t reimburse well.
The more we publicize the fact that it’s
a great operation, the more doctors will
21
take the trouble to learn it. I have written
several instructional articles on it and
the most recent one will be coming out
in OKOJ (Orthopedic Knowledge Online
Journal) soon. And any of my surgeon
colleagues are welcome to come to The
Spine Hospital to watch me perform
this procedure. I do an average of one
per week, at least. We will also be posting a video on the technique soon.”
Surgeons interested in watching Dr. Riew
perform laminoplasty feel free to contact
him at: [email protected] ♦
iFuse Implant System®
Clinical Results: the only SI joint fusion
system with an RCT demonstrating
safety and effectiveness*
* Polly, D.W. et al., Neurosurgery. 2015.— Dr. Polly is an investigator on a clinical research study sponsored by SI-BONE. He has no financial interest in SI-BONE.
Research was funded by SI-BONE, Inc. A list of additional published studies is available at www.si-bone.com/results
The iFuse Implant System® is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began
during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. Clinical studies have demonstrated that treatment with the iFuse Implant System improved pain, patient function, and quality of life
at 12 months post-implantation. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit www.si-bone.com/risks
SI-BONE and iFuse Implant System are registered trademarks of SI-BONE, Inc. © 2016 SI-BONE, Inc. All rights reserved. U.S. Patent Nos. 8,202,305; 8,840,623; 8,986,348 and 9,039,743; pending U.S. and foreign patent applications. 9457.121815
Advertisement
ryortho.com | 1-888-749-2153